Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Wirth

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Virology Journal|September 8, 2006
Caveolin-1 interacts with the Gag precursor of murine leukaemia virus and modulates virus productionZheng Yu, Christiane Beer, Mario Koester, et al.
Der Urologe. Ausg. A|October 21, 2021
[Outpatient urology in Europe]Helmut Haas, Jens Rassweiler, Manfred Wirth, et al.
Biotechnology and Bioengineering|May 4, 2011
Spatiotemporal modeling and analysis of transient gene deliveryUwe Jandt, Shi Shao, Manfred Wirth, et al.
Virology Journal|May 28, 2010
Caveolin-1 influences human influenza A virus (H1N1) multiplication in cell cultureLijing Sun, Gun-Viol Hemgård, Sony A Susanto, et al.
European Urology|July 2, 2019
Reply to Piet R. Dirix, Carole Mercier, and Luc Y. Dirix's Letter to the Editor re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51Tobias Hölscher, Fabian Lohaus, Manfred Wirth, et al.
European Urology|December 31, 2010
Bone turnover markers as predictors of mortality risk in prostate cancer patients with bone metastases following treatment with zoledronic acidKlaus Jung, Kurt Miller, Manfred Wirth, et al.
Urologia Internationalis|June 13, 2015
A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumKurt Miller, Rudolf Morant, Arnulf Stenzl, et al.
Biotechnology and Bioengineering|January 31, 2003
Human c-fos promoter mediates high-level, inducible expression in various mammalian cell linesJing-Xiu Bi, Petra Buhr, An-Ping Zeng, et al.
The Journal of General Virology|June 18, 2003
Gene expression analysis of murine cells producing amphotropic mouse leukaemia virus at a cultivation temperature of 32 and 37 degrees CChristiane Beer, Petra Buhr, Heidi Hahn, et al.
European Urology|June 2, 2009
European Association of Urology position statement on screening for prostate cancerPer-Anders Abrahamsson, Walter Artibani, Christopher R Chapple, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Virology Journal|September 8, 2006
Caveolin-1 interacts with the Gag precursor of murine leukaemia virus and modulates virus productionZheng Yu, Christiane Beer, Mario Koester, et al.
Der Urologe. Ausg. A|October 21, 2021
[Outpatient urology in Europe]Helmut Haas, Jens Rassweiler, Manfred Wirth, et al.
Biotechnology and Bioengineering|May 4, 2011
Spatiotemporal modeling and analysis of transient gene deliveryUwe Jandt, Shi Shao, Manfred Wirth, et al.
Virology Journal|May 28, 2010
Caveolin-1 influences human influenza A virus (H1N1) multiplication in cell cultureLijing Sun, Gun-Viol Hemgård, Sony A Susanto, et al.
European Urology|July 2, 2019
Reply to Piet R. Dirix, Carole Mercier, and Luc Y. Dirix's Letter to the Editor re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51Tobias Hölscher, Fabian Lohaus, Manfred Wirth, et al.
European Urology|December 31, 2010
Bone turnover markers as predictors of mortality risk in prostate cancer patients with bone metastases following treatment with zoledronic acidKlaus Jung, Kurt Miller, Manfred Wirth, et al.
Urologia Internationalis|June 13, 2015
A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumKurt Miller, Rudolf Morant, Arnulf Stenzl, et al.
Biotechnology and Bioengineering|January 31, 2003
Human c-fos promoter mediates high-level, inducible expression in various mammalian cell linesJing-Xiu Bi, Petra Buhr, An-Ping Zeng, et al.
The Journal of General Virology|June 18, 2003
Gene expression analysis of murine cells producing amphotropic mouse leukaemia virus at a cultivation temperature of 32 and 37 degrees CChristiane Beer, Petra Buhr, Heidi Hahn, et al.
European Urology|June 2, 2009
European Association of Urology position statement on screening for prostate cancerPer-Anders Abrahamsson, Walter Artibani, Christopher R Chapple, et al.
Pageof 10